Pricing Log in Create free account

Structure Therapeutics Inc. Sponsored ADR (GPCR) vs Rapport Therapeutics, Inc. (RAPP)

Structure Therapeutics Inc. Sponsored ADR and Rapport Therapeutics, Inc. are both Biotechnology companies. Structure Therapeutics Inc. Sponsored ADR and Rapport Therapeutics, Inc. are of similar size ($1.6B and $1.5B). Across the 8 metrics below, Rapport Therapeutics, Inc. leads on 5 and Structure Therapeutics Inc. Sponsored ADR on 3.

Valuation

Metric GPCR RAPP Biotechnology median
P/E n/m n/m 11.58
P/S n/m n/m 9.61
P/B 1.25 3.28 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales n/m n/m 9.43
Earnings yield (19.04%) (11.80%) (32.28%)
Free cash flow yield (18.23%) (9.40%) (22.27%)

Profitability

Metric GPCR RAPP Biotechnology median
Gross margin 0.00% — 68.81%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (29.51%) (33.33%) (50.30%)
Return on assets (27.13%) (31.55%) (45.47%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GPCR RAPP Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) (2.47%) 24.34% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GPCR RAPP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.91 20.07 4.74
Net debt to EBITDA 8.27 3.91 1.01

Dividend

Metric GPCR RAPP Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric GPCR RAPP Biotechnology median
Market cap 1.49b 1.60b 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack